Takara Bio Inc. announced unaudited consolidated earnings results for the first quarter ended June 30, 2020. For the quarter, the company reported net sales of JPY 6,938 million against JPY 8,650 million a year ago. Operating profit was JPY 693 million against JPY 2,251 million a year ago. Net income attributable to the owners of the parent was JPY 404 million against JPY 1,591 million a year ago. Net income per share was JPY 3.36 against JPY 13.22 a year ago.